Show simple item record

dc.contributor.authorMeijer, Adam
dc.contributor.authorBosman, Arnold
dc.contributor.authorKamp, Esther E H M van de
dc.contributor.authorWilbrink, Berry
dc.contributor.authorDu Ry van Beest Holle, Mirna
dc.contributor.authorKoopmans, Marion P G
dc.date.accessioned2007-01-10T10:24:59Z
dc.date.available2007-01-10T10:24:59Z
dc.date.issued2006-03-01
dc.identifier.citationJ. Virol. Methods 2006, 132(1-2):113-20en
dc.identifier.issn0166-0934
dc.identifier.pmid16271401
dc.identifier.doi10.1016/j.jviromet.2005.10.001
dc.identifier.urihttp://hdl.handle.net/10029/7147
dc.description.abstractDuring the epizootic of highly pathogenic avian influenza A(H7N7) in 2003 in The Netherlands, RT-PCR and culture confirmed infection was detected in 89 persons who were ill. A modified hemagglutination inhibition (HI) test using horse erythrocytes and 2 hemagglutinating units of virus was applied to assess retrospectively the extent of human (subclinical) infection. Validation of the HI-test with sera from 34 RT-PCR and culture confirmed A(H7) infected persons and sera from 100 persons from a human influenza vaccine trial in autumn 2002 showed that this HI-test had a sensitivity of 85% and a specificity of 100% when using a cut-off titer of > or =10. Using this cut-off value, A(H7) specific antibodies were detected in 49% of 508 persons exposed to poultry and in 64% of 63 persons exposed to A(H7) infected persons. Correlation of seropositivity with the occurrence of eye symptoms in exposed persons who had not received antiviral prophylaxis and of reduced seropositivity with taking antiviral prophylaxis provided further evidence that the A(H7) HI antibody titers were real. In conclusion, by applying an HI-test using horse erythrocytes human antibodies against the avian A(H7N7) virus were detected with high sensitivity and specificity in an unexpectedly high proportion of exposed persons.
dc.format.extent217397 bytes
dc.format.mimetypeapplication/pdf
dc.language.isoenen
dc.titleMeasurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test.en
dc.typeArticleen
dc.format.digYES
refterms.dateFOA2018-12-18T11:47:19Z
html.description.abstractDuring the epizootic of highly pathogenic avian influenza A(H7N7) in 2003 in The Netherlands, RT-PCR and culture confirmed infection was detected in 89 persons who were ill. A modified hemagglutination inhibition (HI) test using horse erythrocytes and 2 hemagglutinating units of virus was applied to assess retrospectively the extent of human (subclinical) infection. Validation of the HI-test with sera from 34 RT-PCR and culture confirmed A(H7) infected persons and sera from 100 persons from a human influenza vaccine trial in autumn 2002 showed that this HI-test had a sensitivity of 85% and a specificity of 100% when using a cut-off titer of > or =10. Using this cut-off value, A(H7) specific antibodies were detected in 49% of 508 persons exposed to poultry and in 64% of 63 persons exposed to A(H7) infected persons. Correlation of seropositivity with the occurrence of eye symptoms in exposed persons who had not received antiviral prophylaxis and of reduced seropositivity with taking antiviral prophylaxis provided further evidence that the A(H7) HI antibody titers were real. In conclusion, by applying an HI-test using horse erythrocytes human antibodies against the avian A(H7N7) virus were detected with high sensitivity and specificity in an unexpectedly high proportion of exposed persons.


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
meijer2.pdf
Size:
212.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record